395 related articles for article (PubMed ID: 27608434)
1. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
2. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice.
Bahremand A; Shafaroodi H; Ghasemi M; Nasrabady SE; Gholizadeh S; Dehpour AR
Epilepsy Res; 2008 Sep; 81(1):44-51. PubMed ID: 18502613
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats.
Huizenga MN; Wicker E; Beck VC; Forcelli PA
Epilepsia; 2017 Sep; 58(9):1593-1602. PubMed ID: 28691158
[TBL] [Abstract][Full Text] [Related]
4. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice.
Gholizadeh S; Shafaroodi H; Ghasemi M; Bahremand A; Sharifzadeh M; Dehpour AR
Neuropharmacology; 2007 Nov; 53(6):763-70. PubMed ID: 17870135
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
6. CB2 receptors modulate seizure-induced expression of pro-inflammatory cytokines in the hippocampus but not neocortex.
Karan AA; Spivak YS; Gerasimov KA; Suleymanova EM; Volobueva MN; Kvichansky AA; Vinogradova LV; Bolshakov AP
Mol Neurobiol; 2021 Aug; 58(8):4028-4037. PubMed ID: 33907944
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.
Tchekalarova J; da Conceição Machado K; Gomes Júnior AL; de Carvalho Melo Cavalcante AA; Momchilova A; Tzoneva R
Seizure; 2018 Apr; 57():22-26. PubMed ID: 29547827
[TBL] [Abstract][Full Text] [Related]
8. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
[TBL] [Abstract][Full Text] [Related]
9. Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
Aghaei I; Rostampour M; Shabani M; Naderi N; Motamedi F; Babaei P; Khakpour-Taleghani B
Epilepsy Res; 2015 Nov; 117():23-8. PubMed ID: 26370914
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
11. The role of α₂-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Moezi L; Bahremand A; Dehpour AR
Eur J Pharmacol; 2013 Aug; 714(1-3):1-6. PubMed ID: 23756131
[TBL] [Abstract][Full Text] [Related]
12. The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
Ghanbari MM; Loron AG; Sayyah M
Brain Res Bull; 2021 May; 170():74-80. PubMed ID: 33581310
[TBL] [Abstract][Full Text] [Related]
13. Acute foot-shock stress decreased seizure susceptibility against pentylenetetrazole-induced seizures in mice: Interaction between endogenous opioids and cannabinoids.
Shirzadian A; Ostadhadi S; Hassanipour M; Shafaroodi H; Khoshnoodi M; Haj-Mirzaian A; Sharifzadeh M; Amiri S; Ghasemi M; Dehpour AR
Epilepsy Behav; 2018 Oct; 87():25-31. PubMed ID: 30170259
[TBL] [Abstract][Full Text] [Related]
14. Low-dose cannabinoid receptor 2 agonist induces microglial activation in a cancer pain-morphine tolerance rat model.
Ma C; Zhang M; Liu L; Zhang P; Liu D; Zheng X; Zhong X; Wang G
Life Sci; 2021 Jan; 264():118635. PubMed ID: 33131746
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Diet-Induced Obese Rats with CB
O'Keefe L; Vu T; Simcocks AC; Jenkin KA; Mathai ML; McAinch AJ; Hutchinson DS; Hryciw DH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108770
[TBL] [Abstract][Full Text] [Related]
16. Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat.
Naderi N; Ahmad-Molaei L; Aziz Ahari F; Motamedi F
Neurochem Res; 2011 Aug; 36(8):1520-5. PubMed ID: 21516342
[TBL] [Abstract][Full Text] [Related]
17. The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats.
Al-Kaleel A; Aygun H; Al-Gailani L; Kabak Y; Inal S; Ayyildiz M; Him A; Agar E
Pflugers Arch; 2023 Jun; 475(6):719-730. PubMed ID: 37100982
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
[TBL] [Abstract][Full Text] [Related]
19. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice.
Bahremand A; Nasrabady SE; Shafaroodi H; Ghasemi M; Dehpour AR
Epilepsy Res; 2009 Apr; 84(2-3):110-9. PubMed ID: 19223154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
